Sanotize Research & Development Corporation
Development of anti-microbial medicines from nitric oxide
Based in BC
AI Overview
With $120K in lobbying spend across 9 quarterly filings, Sanotize Research & Development Corporation is an active lobbying client. Their lobbying covers 3 issue areas. Active from 2022 to 2024.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2022 | $18K |
| 2023 | $72K |
| 2024 | $30K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Sanotize Research & Development Corporation disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, MED, Budget/Appropriations
Legislation related to funding for FDA-required trials of a medical device Consultation with United States Health agencie and Military Health Commands about research and development of medicines and m
Seeking funding for Phase III trials of client health product through Congressional appropriations process, specifically the 2023 Omnibus legislation.
Effort to Seek funding for Phase II trials of clients product through the appropriations process, specifically the 2023 Omnibus legislation.
Seeking US federal funding for Phase III trials of client health product through congressional appropriations process, specifically the 2023 Omnibus legislation.
Outreach to Senate HELP committee and House energy & Commerce seeking support for grant research grant efforts with HHS agencies
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.